Stock listing

OTC:EMMA Emmaus Life Sciences, Inc. Stock

Follow Emmaus Life Sciences, Inc. into a list and get an email when it puts out news.

Share price · OTC:EMMA

$0.022 USD +0.001 (+4.3%)

Close on Nov 11, 2026

Past year +93.8% · daily closes, Nov 11, 2025 – Nov 11, 2026, adjusted for splits
Day range
$0.012 – $0.022 USDNov 11, 2026
Volume
19,000 sharesNov 11, 2026
Market cap
$1.54M USDAt the close on Nov 11, 2026 · price × 70.19M shares outstanding
52-week range
$0.0080 – $0.088 USDLowest and highest trades, Nov 12, 2025 – Nov 11, 2026
Traded on an average day
$4,431 USDMedian day 19,864 shares · 14 days with no trades · last 3 months, Aug 11, 2026 – Nov 11, 2026
Emmaus Life Sciences, Inc. logo

Daily closes

Last 3 months, Aug 11, 2026 – Nov 11, 2026 · OTC:EMMA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.022+0.001+4.3%$0.012$0.022$0.01219,000
$0.021-0.004-16.0%$0.025$0.025$0.02118,369
$0.0250.0000.0%$0.025$0.025$0.02518,890
$0.0250.0000.0%$0.025$0.025$0.0250
$0.025-0.002-8.8%$0.032$0.033$0.02550,000
$0.027-0.013-31.5%$0.036$0.036$0.02382,000
$0.040+0.005+13.6%$0.040$0.040$0.04010,000
$0.0350.0000.0%$0.035$0.035$0.0350
$0.0350.0000.0%$0.035$0.035$0.0350
$0.035-0.005-13.5%$0.031$0.035$0.03038,036
$0.041+0.001+1.7%$0.036$0.041$0.0367,202
$0.040-0.006-13.0%$0.046$0.046$0.04041,722
$0.046-0.012-20.1%$0.046$0.046$0.04615,500
$0.0580.0000.0%$0.058$0.058$0.0580
$0.058-0.006-10.0%$0.058$0.058$0.058301
$0.0640.0000.0%$0.064$0.064$0.0640
$0.064+0.014+28.0%$0.046$0.065$0.04620,385
$0.050-0.008-14.4%$0.043$0.056$0.04219,620
$0.0580.0000.0%$0.042$0.065$0.04237,235
$0.0580.0000.0%$0.058$0.058$0.0580
$0.058-0.002-2.7%$0.058$0.058$0.058350
$0.060+0.017+40.2%$0.050$0.060$0.05047,000
$0.0430.0000.0%$0.043$0.043$0.0430
$0.043-0.018-29.0%$0.050$0.050$0.04326,055
$0.060+0.000+0.2%$0.063$0.063$0.06010,800
$0.0600.0000.0%$0.060$0.060$0.0600
$0.0600.0000.0%$0.060$0.060$0.0600
$0.060+0.018+42.7%$0.060$0.060$0.0602,025
$0.042-0.023-35.1%$0.059$0.059$0.04220,250
$0.065-0.001-0.8%$0.065$0.065$0.0593,295
$0.0660.0000.0%$0.066$0.066$0.0660
$0.0660.0000.0%$0.066$0.066$0.0660
$0.066-0.002-3.4%$0.063$0.066$0.0638,435
$0.068+0.006+9.9%$0.068$0.068$0.06214,105
$0.0620.0000.0%$0.062$0.062$0.0620
$0.062-0.003-5.1%$0.063$0.068$0.0626,200
$0.065+0.001+1.6%$0.068$0.068$0.06559,675
$0.064-0.004-5.7%$0.064$0.064$0.0649,920
$0.068+0.013+22.8%$0.065$0.068$0.065110,891
$0.055-0.006-10.4%$0.060$0.065$0.040345,498
$0.062+0.000+0.3%$0.068$0.068$0.05620,108
$0.062-0.007-9.8%$0.063$0.064$0.06220,970
$0.068+0.017+32.2%$0.068$0.068$0.06810,000
$0.0520.0000.0%$0.052$0.052$0.0520
$0.0520.0000.0%$0.052$0.052$0.0520
$0.052-0.013-19.5%$0.064$0.065$0.05238,888
$0.064+0.004+6.5%$0.065$0.065$0.0646,224
$0.060-0.001-1.6%$0.061$0.068$0.06041,376
$0.061-0.010-13.8%$0.080$0.080$0.06144,725
$0.071+0.006+9.2%$0.070$0.080$0.06887,358
$0.065+0.005+8.5%$0.060$0.072$0.054155,520
$0.060-0.023-27.8%$0.088$0.088$0.0371,072,236
$0.083+0.032+62.7%$0.055$0.083$0.047396,664
$0.051+0.009+21.7%$0.042$0.051$0.04192,806
$0.042+0.003+7.4%$0.039$0.043$0.036106,045
$0.039-0.002-4.9%$0.037$0.039$0.031110,822
$0.041+0.009+27.7%$0.032$0.044$0.032373,755
$0.032+0.006+23.0%$0.028$0.032$0.017847,102
$0.026+0.013+102.3%$0.015$0.038$0.0151,506,647
$0.013+0.002+17.3%$0.011$0.013$0.01152,020
$0.011-0.001-4.3%$0.012$0.013$0.0111,089,555
$0.0120.0000.0%$0.013$0.013$0.012323,200
$0.0120.0000.0%$0.012$0.012$0.012120,008
$0.012-0.001-8.0%$0.012$0.012$0.011100,000
$0.013+0.001+8.7%$0.013$0.013$0.013100
$0.0120.0000.0%$0.014$0.014$0.012121,000

Splits

3 splits since 2012 · OTC:EMMA · every price before a split is adjusted for it

DayRatioWhat
1-for-6Consolidation
1-for-200Consolidation
1-for-30Consolidation
Ticker
OTC:EMMA
Asset type
Stock
Exchange
OTC
Currency
USD

What changed lately

Latest news

All Emmaus Life Sciences, Inc. news

Emmaus Life Sciences, Inc. on 6ix

News releases
2 in the last 12 months · 2 in all · newest Nov 19, 2026 · oldest 2026
Decks
15 decks · latest August 2026

Valuation

Statements: 4 quarters to Sep 30, 2026 · price Nov 11, 2026

Enterprise value
$25.59M USD
P/E
Loss
EV/sales
1.8×
EV/EBITDA
7.2×
Price/book
Negative equity
Gross margin
92.0%
Operating margin
24.8%
Net margin
−61.9%
Debt to equity
Negative equity
Beta vs S&P 500
-0.14

Team and board

Officers

OfficerRole
Willis C. LeeChief Executive Officer, Chairman of the Board
Dale E. ShortLegal Consultant and Corporate Secretary
Charles W. StarkSenior Vice President of Medical Affairs, Clinical, Regulatory
Hiroko HuynhChief Accounting Officer

Board

DirectorRole
Willis C. LeeChief Executive Officer, Chairman of the Board
Henry DuDirector
Wei Peu ZenDirector

Events

QuarterResultsShare move
Q3 2025Nov 20, 2025−5.0%
Q2 2025Sep 8, 2025 · Before open−7.6%
Q1 2025Apr 14, 2025+3.2%
Q3 2024Nov 12, 2024 · Before open0.0%
Q2 2024Jul 3, 2024 · Before open+1.3%
Q1 2024Apr 30, 2024 · Before open0.0%
Q4 2023Mar 29, 2024+8.4%
Q3 2023Nov 14, 2023 · Before open0.0%
Q2 2023Aug 14, 2023 · After close0.0%
Q1 2023May 15, 2023 · Before open0.0%
All 19 quarters
QuarterResultsShare move
Q4 2022Mar 31, 2023 · After close−0.2%
Q3 2022Nov 14, 2022 · After close−20.0%
Q2 2022Aug 15, 2022 · After close0.0%
Q1 2022May 13, 2022 · Before open−21.5%
Q4 2021Mar 31, 2022 · After close0.0%
Quarter to Sep 30, 2021Nov 12, 2021 · After close+0.8%
Quarter to Jun 30, 2021Sep 2, 2021 · After close−0.7%
Quarter to Mar 31, 2021May 4, 2021 · Before open−4.2%
Quarter to Dec 31, 2020Jan 25, 2021 · Before open−9.8%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2026)Investor deck27 slidesAugust 2026
Investor Presentation (April 2022)Investor deck31 slidesApril 2022
Investor Presentation (November 2021)Investor deck30 slidesNovember 2021
Shareholder Meeting (October 2020)Shareholder meeting18 slidesOct 29, 2020
MYnd Analytics — Investor Presentation (June 2019)Investor deck25 slidesJun 20, 2019
MYnd Analytics — Merger or Acquisition (March 2019)Merger or acquisition21 slidesMar 5, 2019
MYnd Analytics — JP Morgan Healthcare Conference 2019Conference21 slidesJan 7, 2019
MYnd Analytics — Investor Presentation (September 2018)Investor deck27 slidesSep 6, 2018
MYnd Analytics — Investor Presentation (May 2018)Investor deck25 slidesMay 22, 2018
MYnd Analytics — Investor Presentation (February 2018)Investor deck25 slidesFeb 23, 2018
All 15 decks
DeckKindSlidesDate
MYnd Analytics — Investor Presentation (January 2018)Investor deck25 slidesJan 5, 2018
MYnd Analytics — Investor Presentation (November 2017)Investor deck25 slidesNov 28, 2017
MYnd Analytics — Investor Presentation (July 2017)Investor deck24 slidesJul 28, 2017
MYnd Analytics — IPO Roadshow (July 2017)IPO roadshow25 slidesJul 3, 2017
MYnd Analytics — IPO Roadshow (June 2017)IPO roadshow25 slidesJun 19, 2017

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2018FY2017
Revenue12.5M16.7M29.6M18.4M20.6M23.2M22.8M16.5M1.32M128.5K
Cost of revenue857.0K1.20M1.34M2.59M3.31M2.25M1.09M993.0K827.4K53.5K
Gross profit11.6M15.5M28.3M15.8M17.3M20.9M21.7M15.5M488.1K75.0K
Research and development313.0K657.0K1.19M1.73M4.11M2.41M2.18M1.72M
Operating income231.0K-1.89M3.54M-6.59M-6.13M-32.0K-4.51M-8.45M-10.2M-7.10M
Depreciation and amortization39.0K22.0K32.0K53.0K59.0K60.0K73.0K61.0K117.9K48.7K
EBITDA270.0K-1.87M3.57M-6.53M-6.07M28.0K-4.44M-8.39M-10.1M-7.05M
Interest expense7.13M5.49M7.38M5.01M3.10M5.99M27.6M22.8M
Income before tax-7.48M-6.42M-3.79M-10.6M-15.9M973.0K-54.7M-72.5M-10.3M-7.11M
Income tax9.00K29.0K-59.0K60.0K25.0K-381.0K164.0K39.0K1.90K2.60K
Net income-7.49M-6.45M-3.73M-10.6M-15.9M1.35M-54.8M-72.6M-9.60M-7.11M
Earnings per share, basic-0.12-0.10-0.07-0.21-0.3230.00-1.30-1.97-1.86-2.52
Earnings per share, diluted-0.12-0.10-0.07-0.21-0.3230.00-1.30-1.97-1.86-2.52

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2018FY2017
Cash and equivalents2.13M1.39M2.55M2.02M2.28M2.49M1.77M3.90M3.25M5.45M
Short-term investments27.9M49.3M
Receivables2.80M2.62M5.52M375.0K1.04M198.0K2.15M1.79M63.3K6.50K
Inventory1.55M1.64M1.71M2.38M4.39M7.09M7.97M4.71M
Current assets7.75M6.77M11.5M6.29M9.09M11.3M41.2M60.6M3.51M5.69M
Property, plant and equipment113.0K46.0K59.0K75.0K147.0K120.0K151.0K152.0K110.8K120.7K
Goodwill1.39M1.39M
Total assets21.4M23.6M35.2M48.2M56.7M59.5M59.5M75.3M5.15M6.10M
Accounts payable5.98M5.17M5.11M3.79M2.72M2.02M7.28M3.47M346.9K736.9K
Current liabilities69.1M63.6M61.5M54.3M37.1M23.4M32.8M45.6M1.17M1.55M
Long-term debt597.1K587.7K
Total debt27.1M29.0M30.6M30.4M22.3M15.3M597.1K587.7K
Total liabilities85.0M80.1M82.9M82.3M78.2M64.7M70.5M97.0M1.87M1.55M
Shareholders' equity-63.6M-56.5M-47.8M-34.1M-21.4M-5.16M-11.1M-21.7M4.02M4.55M
Shares outstanding70.2M63.9M61.8M49.6M49.3M49.0M48.5M37.3M7.41M4.30M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2018FY2017
Cash from operations-11.0K-2.29M-1.50M-5.07M-1.25M-2.45M-4.52M-5.63M-9.04M-4.79M
Capital spending-1.00K-12.0K-17.0K-26.0K-73.0K-15.0K-60.0K-94.0K-55.2K-127.9K
Free cash flow-12.0K-2.30M-1.52M-5.10M-1.33M-2.47M-4.58M-5.73M-9.09M-4.92M
Cash from investing2.17M2.50M-432.0K-2.39M-6.38M5.47M-1.48M-7.44M-361.8K-479.5K
Cash from financing-1.43M-1.35M2.48M7.23M7.41M-2.31M3.88M-5.58M7.21M10.4M
Change in cash738.0K-1.16M526.0K-258.0K-208.0K718.0K-2.14M-18.7M-2.19M5.13M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 18, 2026ResultsSEC
10-Q · Quarterly reportNov 18, 2026Quarterly reportSEC
NT 10-Q · Late filing noticeNov 16, 2026Explanation requestSEC
4 · Change in ownershipSep 2, 2026Insider tradeSEC
8-K · Current reportAug 14, 2026ResultsSEC
10-Q · Quarterly reportAug 14, 2026Quarterly reportSEC
8-K · Current reportMay 15, 2026ResultsSEC
10-Q · Quarterly reportMay 15, 2026Quarterly reportSEC
3 · Initial statement of ownershipApr 21, 2026Insider tradeSEC
8-K · Current reportApr 17, 2026Management or board changeSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportApr 14, 2026Management or board changeSEC
8-K · Current reportMar 31, 2026ResultsSEC
10-K · Annual reportMar 30, 2026Annual reportSEC
8-K · Current reportMar 4, 2026Material contractSEC
8-K · Current reportDec 30, 2025Material contractSEC
8-K · Current reportDec 22, 2025Material contractSEC
8-K · Current reportDec 19, 2025Management or board changeSEC
8-K · Current reportNov 14, 2025ResultsSEC
10-Q · Quarterly reportNov 14, 2025Quarterly reportSEC
8-K · Current reportAug 14, 2025ResultsSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
8-K · Current reportJul 1, 2025Management or board changeSEC
8-K · Current reportMay 15, 2025ResultsSEC
10-Q · Quarterly reportMay 15, 2025Quarterly reportSEC
8-K · Current reportMay 5, 2025Current reportSEC
8-K · Current reportApr 14, 2025ResultsSEC
10-K · Annual reportApr 14, 2025Annual reportSEC
NT 10-K · Late filing noticeApr 1, 2025Explanation requestSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 4, 2025Big-stake noticeSEC
8-K · Current reportNov 19, 2024ResultsSEC
10-Q · Quarterly reportNov 19, 2024Quarterly reportSEC
NT 10-Q · Late filing noticeNov 14, 2024Explanation requestSEC
8-K · Current reportNov 6, 2024Management or board changeSEC
8-K · Current reportOct 25, 2024Current reportSEC
3 · Initial statement of ownershipOct 9, 2024Insider tradeSEC
8-K · Current reportOct 4, 2024Management or board changeSEC
4 · Change in ownershipSep 18, 2024Insider tradeSEC
8-K · Current reportSep 10, 2024ResultsSEC
10-Q · Quarterly reportSep 10, 2024Quarterly reportSEC
10-Q · Quarterly reportSep 10, 2024Quarterly reportSEC
NT 10-Q · Late filing noticeAug 15, 2024Explanation requestSEC
8-K · Current reportJul 17, 2024Management or board changeSEC
8-K · Current reportJul 3, 2024ResultsSEC
10-K · Annual reportJul 2, 2024Annual reportSEC
8-K · Current reportMay 28, 2024Current reportSEC
NT 10-K · Late filing noticeApr 1, 2024Explanation requestSEC
4 · Change in ownershipFeb 29, 2024Insider tradeSEC
8-K · Current reportFeb 26, 2024Material contractSEC
4 · Change in ownershipFeb 5, 2024Insider tradeSEC
4 · Change in ownershipFeb 5, 2024Insider tradeSEC
4 · Change in ownershipFeb 5, 2024Insider tradeSEC
4 · Change in ownershipFeb 5, 2024Insider tradeSEC
4 · Change in ownershipFeb 5, 2024Insider tradeSEC
4 · Change in ownershipFeb 5, 2024Insider tradeSEC
4 · Change in ownershipFeb 5, 2024Insider tradeSEC
4/A · Change in ownership, amendedJan 3, 2024Insider tradeSEC
SC 13G · Big-stake noticeDec 22, 2023Big-stake noticeSEC
4 · Change in ownershipDec 21, 2023Insider tradeSEC
3/A · Initial statement of ownership, amendedDec 20, 2023Insider tradeSEC
4 · Change in ownershipDec 19, 2023Insider tradeSEC
4 · Change in ownershipDec 19, 2023Insider tradeSEC
8-K · Current reportDec 19, 2023Material contractSEC
4 · Change in ownershipDec 4, 2023Insider tradeSEC
8-K · Current reportNov 14, 2023ResultsSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
8-K · Current reportOct 4, 2023Management or board changeSEC
8-K · Current reportAug 23, 2023Management or board changeSEC
8-K · Current reportAug 14, 2023ResultsSEC
10-Q · Quarterly reportAug 14, 2023Quarterly reportSEC
4 · Change in ownershipJun 2, 2023Insider tradeSEC
8-K · Current reportMay 15, 2023ResultsSEC
10-Q · Quarterly reportMay 12, 2023Quarterly reportSEC
8-K · Current reportMar 31, 2023ResultsSEC
10-K · Annual reportMar 31, 2023Annual reportSEC
8-K · Current reportMar 6, 2023FinancingSEC
SC 13D/A · Big-stake notice, amendedFeb 21, 2023Big-stake noticeSEC
DJan 31, 2023Other filingsSEC
4 · Change in ownershipJan 20, 2023Insider tradeSEC
DJan 20, 2023Other filingsSEC
4/A · Change in ownership, amendedJan 19, 2023Insider tradeSEC
8-K · Current reportJan 19, 2023Management or board changeSEC
4 · Change in ownershipJan 17, 2023Insider tradeSEC
4 · Change in ownershipJan 17, 2023Insider tradeSEC
4 · Change in ownershipJan 17, 2023Insider tradeSEC
4 · Change in ownershipJan 17, 2023Insider tradeSEC
4 · Change in ownershipJan 17, 2023Insider tradeSEC
4 · Change in ownershipJan 17, 2023Insider tradeSEC
4 · Change in ownershipJan 17, 2023Insider tradeSEC
4 · Change in ownershipJan 17, 2023Insider tradeSEC
8-K · Current reportDec 9, 2022Meeting outcomeSEC
4 · Change in ownershipDec 1, 2022Insider tradeSEC
8-K · Current reportNov 14, 2022ResultsSEC
10-Q · Quarterly reportNov 14, 2022Quarterly reportSEC
SC 13D/A · Big-stake notice, amendedNov 9, 2022Big-stake noticeSEC
4 · Change in ownershipNov 3, 2022Insider tradeSEC
4 · Change in ownershipOct 31, 2022Insider tradeSEC
DEF 14A · Proxy statementOct 31, 2022Meeting noticeSEC
4 · Change in ownershipOct 24, 2022Insider tradeSEC
PRE 14A · Preliminary proxy statementOct 21, 2022Meeting noticeSEC
4 · Change in ownershipOct 19, 2022Insider tradeSEC
4 · Change in ownershipOct 17, 2022Insider tradeSEC
4 · Change in ownershipOct 13, 2022Insider tradeSEC
4 · Change in ownershipOct 12, 2022Insider tradeSEC
3 · Initial statement of ownershipOct 6, 2022Insider tradeSEC
3 · Initial statement of ownershipOct 6, 2022Insider tradeSEC
8-K · Current reportOct 6, 2022Management or board changeSEC
8-K · Current reportSep 30, 2022Management or board changeSEC
8-K · Current reportAug 19, 2022Material contractSEC
8-K · Current reportAug 15, 2022ResultsSEC
10-Q · Quarterly reportAug 15, 2022Quarterly reportSEC
8-K · Current reportAug 10, 2022Management or board changeSEC
4 · Change in ownershipJul 25, 2022Insider tradeSEC
10-K/A · Annual report, amendedJul 1, 2022Annual reportSEC
DJun 30, 2022Other filingsSEC
8-K · Current reportJun 10, 2022Management or board changeSEC
4 · Change in ownershipJun 3, 2022Insider tradeSEC
4 · Change in ownershipJun 2, 2022Insider tradeSEC
4 · Change in ownershipMay 19, 2022Insider tradeSEC
8-K · Current reportMay 13, 2022ResultsSEC
10-Q · Quarterly reportMay 12, 2022Quarterly reportSEC
4 · Change in ownershipApr 12, 2022Insider tradeSEC
8-K · Current reportMar 31, 2022ResultsSEC
10-K · Annual reportMar 31, 2022Annual reportSEC
4 · Change in ownershipMar 2, 2022Insider tradeSEC
4 · Change in ownershipFeb 28, 2022Insider tradeSEC
4 · Change in ownershipFeb 28, 2022Insider tradeSEC
4 · Change in ownershipFeb 23, 2022Insider tradeSEC
4 · Change in ownershipFeb 18, 2022Insider tradeSEC
SC 13D/A · Big-stake notice, amendedFeb 16, 2022Big-stake noticeSEC
4 · Change in ownershipFeb 16, 2022Insider tradeSEC
4 · Change in ownershipFeb 11, 2022Insider tradeSEC
4 · Change in ownershipFeb 9, 2022Insider tradeSEC
4 · Change in ownershipFeb 7, 2022Insider tradeSEC
3 · Initial statement of ownershipJan 24, 2022Insider tradeSEC
8-K · Current reportJan 10, 2022Management or board changeSEC
4 · Change in ownershipJan 5, 2022Insider tradeSEC
4 · Change in ownershipJan 5, 2022Insider tradeSEC
4 · Change in ownershipJan 3, 2022Insider tradeSEC
S-8 · Registration statement for employee plansDec 30, 2021Offer documentSEC
3 · Initial statement of ownershipDec 28, 2021Insider tradeSEC
4 · Change in ownershipDec 28, 2021Insider tradeSEC
4 · Change in ownershipDec 22, 2021Insider tradeSEC
3 · Initial statement of ownershipDec 20, 2021Insider tradeSEC
4 · Change in ownershipDec 17, 2021Insider tradeSEC
4 · Change in ownershipDec 10, 2021Insider tradeSEC
4 · Change in ownershipDec 6, 2021Insider tradeSEC
4 · Change in ownershipDec 2, 2021Insider tradeSEC
SC 13D/A · Big-stake notice, amendedDec 1, 2021Big-stake noticeSEC
3 · Initial statement of ownershipNov 30, 2021Insider tradeSEC
4 · Change in ownershipNov 30, 2021Insider tradeSEC
4 · Change in ownershipNov 30, 2021Insider tradeSEC
8-K · Current reportNov 29, 2021Management or board changeSEC
4 · Change in ownershipNov 26, 2021Insider tradeSEC
4 · Change in ownershipNov 26, 2021Insider tradeSEC
4 · Change in ownershipNov 23, 2021Insider tradeSEC
4 · Change in ownershipNov 23, 2021Insider tradeSEC
4 · Change in ownershipNov 19, 2021Insider tradeSEC
10-Q · Quarterly reportNov 12, 2021Quarterly reportSEC
4 · Change in ownershipOct 22, 2021Insider tradeSEC
DEF 14A · Proxy statementOct 12, 2021Meeting noticeSEC
8-K · Current reportOct 12, 2021Material contractSEC
4 · Change in ownershipOct 7, 2021Insider tradeSEC
PRE 14A · Preliminary proxy statementSep 30, 2021Meeting noticeSEC
4 · Change in ownershipSep 29, 2021Insider tradeSEC
4 · Change in ownershipSep 27, 2021Insider tradeSEC
4 · Change in ownershipSep 23, 2021Insider tradeSEC
4 · Change in ownershipSep 17, 2021Insider tradeSEC
4 · Change in ownershipSep 17, 2021Insider tradeSEC
4 · Change in ownershipSep 13, 2021Insider tradeSEC
4 · Change in ownershipSep 10, 2021Insider tradeSEC
4 · Change in ownershipSep 8, 2021Insider tradeSEC
4 · Change in ownershipSep 2, 2021Insider tradeSEC
10-Q · Quarterly reportSep 1, 2021Quarterly reportSEC
10-Q · Quarterly reportSep 1, 2021Quarterly reportSEC
4 · Change in ownershipAug 27, 2021Insider tradeSEC
4 · Change in ownershipAug 26, 2021Insider tradeSEC
10-Q · Quarterly reportAug 25, 2021Quarterly reportSEC
10-Q · Quarterly reportAug 25, 2021Quarterly reportSEC
10-Q · Quarterly reportAug 25, 2021Quarterly reportSEC
4 · Change in ownershipAug 23, 2021Insider tradeSEC
4 · Change in ownershipAug 18, 2021Insider tradeSEC
4 · Change in ownershipAug 13, 2021Insider tradeSEC
4 · Change in ownershipAug 10, 2021Insider tradeSEC
10-K/A · Annual report, amendedAug 9, 2021Annual reportSEC
8-K · Current reportAug 9, 2021Current reportSEC
4 · Change in ownershipAug 5, 2021Insider tradeSEC
4 · Change in ownershipAug 2, 2021Insider tradeSEC
4 · Change in ownershipJul 28, 2021Insider tradeSEC
4 · Change in ownershipJul 23, 2021Insider tradeSEC
SC 13D/A · Big-stake notice, amendedJul 22, 2021Big-stake noticeSEC
4 · Change in ownershipJul 20, 2021Insider tradeSEC
4 · Change in ownershipJul 15, 2021Insider tradeSEC
4 · Change in ownershipJul 12, 2021Insider tradeSEC
4 · Change in ownershipJul 7, 2021Insider tradeSEC
4 · Change in ownershipJul 1, 2021Insider tradeSEC
4 · Change in ownershipJun 28, 2021Insider tradeSEC
4 · Change in ownershipJun 22, 2021Insider tradeSEC
4 · Change in ownershipJun 17, 2021Insider tradeSEC
4 · Change in ownershipJun 14, 2021Insider tradeSEC
4 · Change in ownershipJun 9, 2021Insider tradeSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Emmaus Life Sciences, Inc.’s releases · as of Nov 11, 2026

Common shares
70,188,263
Fully diluted
70,188,263

Fully diluted

LineSharesAs of
Common shares70,188,263Nov 11, 2026

Share count over time

CountShares
Nov 11, 202670,188,263

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Robin L. Smith
Other companies: Matinas BioPharma Holdings, Inc. (Director · Feb 13, 2025 – Nov 4, 2026 · Past); Cycurion, Inc. (Director · Jan 11, 2022 – Jan 11, 2022 · Past); Celularity Inc. (Director · Jul 16, 2021 – Jun 14, 2023 · Past); ServiceSource International Inc (Director · Feb 27, 2020 – May 20, 2020 · Past); Sorrento Therapeutics, Inc. (Director · Dec 16, 2019 – Sep 3, 2021 · Past); Rockwell Medical, Inc. (Director · Jun 6, 2019 – Jun 6, 2019 · Past)
Director · May 8, 2019 – May 8, 2019 · Past
Geoffrey E Harris
Other companies: Vyant Bio Inc (Director · Mar 30, 2021 – Jan 17, 2023 · Past); Cancer Genetics Inc (Director · Sep 28, 2017 – Jul 23, 2019 · Past)
Director · Dec 5, 2017 – Oct 8, 2018 · Past
John Pappajohn
Other companies: American Caresource Holdings Inc (Director · Aug 28, 2015 – Jun 30, 2016 · Past); Cancer Genetics Inc (Director · Aug 26, 2015 – Jan 31, 2019 · Past)
Director · Aug 20, 2015 – May 23, 2019 · Past
Jane Pine Wood
Other companies: Aspira Women's Health Inc. (Board Member · Since at least Jul 11, 2025)
Director · Mar 25, 2020 – Mar 25, 2020 · Past
Jon Kuwahara
Other companies: Eledon Pharmaceuticals, Inc. (See Remarks · May 20, 2019 – Sep 11, 2020 · Past)
Director · Oct 1, 2024 – Oct 1, 2024 · Past
Michal Votruba
Other companies: BioXcel Therapeutics, Inc. (Director · Since at least Mar 7, 2019)
Director · Jul 30, 2015 – Oct 8, 2018 · Past
Alfred Fu Kong LuiDirector · Nov 23, 2021 – Jan 3, 2022 · Past
Charles W. StarkSenior Vice President of Medical Affairs, Clinical, Regulatory · Since at least Nov 4, 2026
Dale E. ShortLegal Consultant and Corporate Secretary · Since at least Nov 5, 2026
George SekulichCo-President & CCO, Director · Nov 23, 2021 – Feb 1, 2024 · Past
All 18 people
PersonSeat
Henry DuDirector · Since at least Nov 5, 2026
Hiroko HuynhChief Accounting Officer · Since at least Nov 4, 2026
Ian Harvey ZwickerDirector · Jul 17, 2019 – Feb 1, 2024 · Past
Paul BuckChief Financial Officer · Feb 15, 2011 – Nov 1, 2016 · Past
Seah H LimDirector · Oct 4, 2022 – Sep 16, 2024 · Past
Wei Peu ZenDirector · Since at least Nov 5, 2026
Willis C. LeeCEO, Director · Since at least Apr 4, 2022
Yasushi NagasakiCFO · Jan 12, 2023 – Feb 1, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Emmaus Life Sciences, Inc.